Pregled bibliografske jedinice broj: 1157275
Role of F-18-choline PET/CT in staging of prostate cancer
Role of F-18-choline PET/CT in staging of prostate cancer // 10th International congress of the Croatian society of nuclear medicine
Vodice, Hrvatska, 2021. (predavanje, međunarodna recenzija, neobjavljeni rad, stručni)
CROSBI ID: 1157275 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Role of F-18-choline PET/CT in staging of prostate cancer
Autori
Golubić, Anja Tea ; Gamulin, Marija ; Solarić, Mladen ; Kuliš, Tomislav ; Kaštelan, Željko ; Huić, Dražen
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, neobjavljeni rad, stručni
Skup
10th International congress of the Croatian society of nuclear medicine
Mjesto i datum
Vodice, Hrvatska, 03.09.2021. - 05.09.2021
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
F-18-choline ; prostate cancer ; staging
Sažetak
Introduction: The aim of this study was to evaluate the value of F-18 choline PET/CT in initial staging of high-risk prostate cancer patients. Subjects and methods: Hundred consecutive biopsy confirmed prostate cancer patients were scanned with F-18-choline PET/CT from February 2012 to April 2018. Mean PSA value at referral was 48, 4 ng/ml (range 4, 3 to 280, 6). Functional imaging was proposed in high risk patients and after equivocal conventional imaging and bone scintigraphy findings. Imaging was performed after administration of F-18 choline (2- 3 MBq/kg, mean 209 MBq). All patients had a minimum 6-month follow-up. Results: There were 24 patients without metastases, while the majority of patients (76%) had a choline scan positive for metastatic disease. Eight patients had a single positive pelvic lymph node, with a short axis diameter shorter than 1 cm. 56 patients had FCH positive metastastic disease in lymph nodes only (mean SUV 6, 4), 25 in lymph nodes and/or skeleton (mean SUV 10, 7). In sixteen patients seminal vesicles’ infiltration was found. Majority of our patient population had a combination of radiotherapy and hormonal therapy, with the mean PSA levels after six months significantly lower (2, 1 ng/ml). Conclusion: F-18-choline PET/CT provides clinicians with valuable information in staging of high-risk prostate cancer. It has an important impact on therapeutic strategy, providing additional data necessary for the appropriate and individual patient management.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Tomislav Kuliš
(autor)
Anja Tea Golubić
(autor)
Željko Kaštelan
(autor)
Marija Gamulin
(autor)
Dražen Huić
(autor)